Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 892 Financials 884 Information Technology 517 Industrials 386 Consumer Discretionary 320 Communication Services 200 Consumer Staples 114 Materials 78 Energy 67 Real Estate 64 Utilities 27

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 471 Pharmaceuticals 159 Healthcare Equipment & Supplies 138 Healthcare Providers & Services 61 Life Sciences Tools & Services 38 Health Care Technology 25
Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Black Diamond Therapeutics Inc (BDTX)
Fair Value-6.3% Downside Fair Analyst405.1% Upside Market Cap113.8 M P/E— Yield0.0% HealthFair
  NASDAQ
Bolt Biotherapeutics (BOLT)
Fair Value18.0% Upside Fair Analyst681.7% Upside Market Cap7.147 M P/E— Yield0.0% HealthFair
  NASDAQ
Briacell Therapeutics Corp (BCTX)
Fair Value15.3% Upside Fair Market Cap35.503 M P/E— Yield0.0% HealthFair
  NASDAQ
BridgeBio Pharma Inc (BBIO)
Fair Value-8.7% Downside Fair Analyst57.5% Upside Market Cap13.534 B P/E— Yield0.0% HealthFair
  NASDAQ
Burning Rock Biotech Ltd (BNR)
Fair Value14.3% Upside Fair Market Cap173.5 M P/E— Yield0.0% HealthFair
  NASDAQ
C4 Therapeutics Inc (CCCC)
Fair Value9.9% Upside Fair Analyst302.8% Upside Market Cap407.2 M P/E— Yield0.0% HealthFair
  NASDAQ
Cabaletta Bio Inc (CABA)
Fair Value22.0% Upside Undervalued Analyst430.0% Upside Market Cap423.9 M P/E— Yield0.0% HealthWeak
  NASDAQ
Candel Therapeutics Inc (CADL)
Fair Value-6.2% Downside Fair Analyst83.5% Upside Market Cap906.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Caribou Biosciences Inc (CRBU)
Fair Value37.5% Upside Undervalued Analyst784.9% Upside Market Cap143.7 M P/E— Yield0.0% HealthFair
  NASDAQ
Celularity Inc (CELU)
Fair Value57.3% Upside Bargain Market Cap34.156 M P/E— Yield0.0% HealthFair
  NASDAQ
Century Therapeutics Inc (IPSC)
Fair Value8.1% Upside Fair Analyst151.3% Upside Market Cap342.2 M P/E— Yield0.0% HealthFair
  NASDAQ
Chemomab Therapeutics Ltd DRC (CMMB)
Fair Value-13.6% Downside Fair Analyst110.1% Upside Market Cap17.245 M P/E— Yield0.0% HealthGood
  NASDAQ
Cibus Inc (CBUS)
Fair Value-11.8% Downside Fair Analyst801.5% Upside Market Cap121.5 M P/E— Yield0.0% HealthFair
  NASDAQ
Clene Inc. (CLNN)
Fair Value1.5% Upside Fair Analyst635.2% Upside Market Cap56.276 M P/E— Yield0.0% HealthFair
  NASDAQ Featured in Today's Top Gainers
Climb Bio Inc (CLYM)
Fair Value-1.1% Downside Fair Analyst94.0% Upside Market Cap816.2 M P/E— Yield0.0% HealthFair
  NASDAQ
Compass Pathways Plc (CMPS)
Fair Value-4.3% Downside Fair Analyst60.7% Upside Market Cap2.047 B P/E— Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Momentum
Connect Biopharma Holdings Ltd (CNTB)
Fair Value13.8% Upside Fair Analyst435.0% Upside Market Cap76.514 M P/E— Yield0.0% HealthWeak
  NASDAQ
Cullinan Oncology LLC (CGEM)
Fair Value-25.2% Downside Overvalued Analyst54.8% Upside Market Cap1.395 B P/E— Yield0.0% HealthFair
  NASDAQ
Cyclerion Therapeutics Inc (CYCN)
  NASDAQ
Damora Therapeutics Inc (DMRA)
Fair Value-14.0% Downside Fair Analyst99.3% Upside Market Cap1.383 B P/E— Yield0.0% HealthFair
  NASDAQ
Dermata Therapeutics Inc (DRMA)
Fair Value11.7% Upside Fair Analyst247.8% Upside Market Cap4.625 M P/E— Yield0.0% HealthWeak
  NASDAQ
Design Therapeutics Inc (DSGN)
Fair Value-34.6% Downside Overvalued Analyst59.6% Upside Market Cap823.6 M P/E— Yield0.0% HealthFair
  NASDAQ
DiaMedica Therapeutics Inc (DMAC)
Fair Value-36.7% Downside Overvalued Analyst99.2% Upside Market Cap419.5 M P/E— Yield0.0% HealthFair
  NASDAQ
Dianthus Therapeutics Inc (DNTH)
Fair Value-20.8% Downside Overvalued Analyst43.2% Upside Market Cap5.501 B P/E— Yield0.0% HealthFair
  NASDAQ
Disc Medicine Inc (IRON)
Fair Value1.6% Upside Fair Analyst50.7% Upside Market Cap2.629 B P/E— Yield0.0% HealthFair
  NASDAQ
Dogwood Therapeutics Inc (DWTX)
Fair Value44.5% Upside Undervalued Analyst827.2% Upside Market Cap51.329 M P/E— Yield0.0% HealthFair
  NASDAQ
Dyne Therapeutics Inc (DYN)
Fair Value-4.0% Downside Fair Analyst117.0% Upside Market Cap3.201 B P/E— Yield0.0% HealthWeak
  NASDAQ
Elicio Therapeutics Inc (ELTX)
Fair Value7.4% Upside Fair Analyst782.4% Upside Market Cap49.147 M P/E— Yield0.0% HealthWeak
  NASDAQ
Elutia Inc (ELUT)
Fair Value-6.7% Downside Fair Analyst517.3% Upside Market Cap35.883 M P/E— Yield0.0% HealthFair
  NASDAQ
Equillium Inc (EQ)
Fair Value-3.8% Downside Fair Analyst343.3% Upside Market Cap122.4 M P/E— Yield0.0% HealthFair
  NASDAQ
Erasca Inc (ERAS)
Fair Value-35.2% Downside Overvalued Analyst55.1% Upside Market Cap5.439 B P/E— Yield0.0% HealthFair
  NASDAQ
Evaxion AS (EVAX)
Fair Value45.6% Upside Undervalued Analyst244.0% Upside Market Cap27.273 M P/E— Yield0.0% HealthGood
  NASDAQ
Exagen Inc (XGN)
Fair Value-43.7% Downside Overvalued Analyst12.8% Upside Market Cap211.7 M P/E— Yield0.0% HealthGood
  NASDAQ Featured in High-Momentum Stocks High-Beta Momentum
Exicure Inc (XCUR)
Fair Value16.9% Upside Fair Market Cap8.444 M P/E— Yield0.0% HealthFair
  NASDAQ
Foghorn Therapeutics Inc (FHTX)
Fair Value10.1% Upside Fair Analyst169.9% Upside Market Cap251.8 M P/E— Yield0.0% HealthFair
  NASDAQ
Gain Therapeutics Inc (GANX)
Fair Value-11.7% Downside Fair Analyst269.2% Upside Market Cap85.105 M P/E— Yield0.0% HealthFair
  NASDAQ
Gossamer Bio Inc (GOSS)
Fair Value36.0% Upside Undervalued Analyst947.7% Upside Market Cap71.433 M P/E— Yield0.0% HealthWeak
  NASDAQ
Greenwich Lifesciences Inc (GLSI)
Fair Value-32.9% Downside Overvalued Analyst192.6% Upside Market Cap285.9 M P/E— Yield0.0% HealthWeak
  NASDAQ
GRI Bio Inc (GRI)
Fair Value25.3% Upside Undervalued Analyst802.4% Upside Market Cap4.482 M P/E— Yield0.0% HealthFair
  NASDAQ
HCW Biologics Inc (HCWB)
Fair Value19.6% Upside Undervalued Market Cap3.324 M P/E— Yield0.0% HealthFair
  NASDAQ
Humacyte Inc (HUMA)
Fair Value45.2% Upside Undervalued Analyst217.3% Upside Market Cap161.9 M P/E— Yield0.0% HealthWeak
  NASDAQ
I Mab (NBP)
Fair Value55.5% Upside Bargain Analyst466.0% Upside Market Cap184.4 M P/E— Yield0.0% HealthFair
  NASDAQ
Ideaya Biosciences Inc (IDYA)
Fair Value-9.9% Downside Fair Analyst31.9% Upside Market Cap3.832 B P/E— Yield0.0% HealthGood
  NASDAQ
Immatics NV (IMTX)
Fair Value-1.3% Downside Fair Analyst98.8% Upside Market Cap1.212 B P/E— Yield0.0% HealthFair
  NASDAQ
Immuneering Corp (IMRX)
Fair Value20.2% Upside Undervalued Analyst272.4% Upside Market Cap298.3 M P/E— Yield0.0% HealthFair
  NASDAQ
Immunocore Holdings PLC (IMCR)
Fair Value10.7% Upside Fair Analyst92.8% Upside Market Cap1.67 B P/E— Yield0.0% HealthFair
  NASDAQ
Immunome Inc (IMNM)
Fair Value2.9% Upside Fair Analyst39.8% Upside Market Cap2.925 B P/E— Yield0.0% HealthFair
  NASDAQ
Immunovant Inc (IMVT)
Fair Value-25.8% Downside Overvalued Analyst31.1% Upside Market Cap7.702 B P/E— Yield0.0% HealthFair
  NASDAQ
In8bio Inc (INAB)
Fair Value34.3% Upside Undervalued Analyst514.0% Upside Market Cap11.239 M P/E— Yield0.0% HealthFair
  NASDAQ
Inhibikase Therapeutics Inc (IKT)
Fair Value-17.6% Downside Fair Analyst159.7% Upside Market Cap420.6 M P/E— Yield0.0% HealthFair
  NASDAQ
Explore listed stocks on NASDAQ with company information and fair value data.